Global Solid Tumor Therapeutics Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application
Report Code: KNJ1408835
Publisher: Date of Publish:
No. of Pages: 103 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst. Market Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Solid Tumor Therapeutics estimated at US$ 132070 million in the year 2022, is projected to reach a revised size of US$ 215470 million by 2028, growing at a CAGR of 8.5% during the forecast period 2022-2028. Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the global solid tumor therapeutics market. Report Scope This report aims to provide a comprehensive presentation of the global market for Solid Tumor Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Therapeutics. The Solid Tumor Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Solid Tumor Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Tumor Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. Market Segmentation This report covers the Solid Tumor Therapeutics segments by manufacturers, by type, by application, by region and country, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. By Company Hoffmann-La Roche Johnson & Johnson Novartis AstraZeneca Biogen Idec Boehringer Ingelheim GlaxoSmithKline Eli Lilly Kyowa Hakko Kirin Abbott Laboratories Baxter International Solid Tumor Therapeutics Segment by Type Chemotherapy Hormone Therapy Immunotherapy Targeted Therapy Solid Tumor Therapeutics Segment by Application Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Cervical Cancer Others Solid Tumor Therapeutics Segment by Region North America (USA, Canada, Mexico) Europe (Germany, the U.K., France, Russia, Italy, Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) South America (Brazil, Rest of South America) Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA) Reasons to Buy This Report Informative and detailed data, historical and forecast revenue data, which is analyzed to tell you why your market is set to change. Provision of market value (USD million) data for each segment and sub-segment. This report will help stakeholders to understand the global industry status and trends of Solid Tumor Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities. This enables you to anticipate market changes to remain ahead of your competitors. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly. This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Solid Tumor Therapeutics industry. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Core Chapters Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2017-2022, 2023-2028). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter Two: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter Three: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter Four: Detailed analysis of Solid Tumor Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc. Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc. Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country. Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter Twelve: Research Finding/Conclusion
1 Market Overview of Solid Tumor Therapeutics 1.1 Solid Tumor Therapeutics Market Overview 1.1.1 Solid Tumor Therapeutics Product Scope 1.1.2 Solid Tumor Therapeutics Market Status and Outlook 1.2 Global Solid Tumor Therapeutics Market Size Overview by Region 2017 VS 2021 VS 2028 1.3 Global Solid Tumor Therapeutics Market Size by Region (2017-2028) 1.4 Global Solid Tumor Therapeutics Historic Market Size by Region (2017-2022) 1.5 Global Solid Tumor Therapeutics Market Size Forecast by Region (2023-2028) 1.6 Key Regions, Solid Tumor Therapeutics Market Size (2017-2028) 1.6.1 North America Solid Tumor Therapeutics Market Size (2017-2028) 1.6.2 Europe Solid Tumor Therapeutics Market Size (2017-2028) 1.6.3 Asia-Pacific Solid Tumor Therapeutics Market Size (2017-2028) 1.6.4 Latin America Solid Tumor Therapeutics Market Size (2017-2028) 1.6.5 Middle East & Africa Solid Tumor Therapeutics Market Size (2017-2028) 2 Solid Tumor Therapeutics Market Overview by Type 2.1 Global Solid Tumor Therapeutics Market Size by Type: 2017 VS 2021 VS 2028 2.2 Global Solid Tumor Therapeutics Historic Market Size by Type (2017-2022) 2.3 Global Solid Tumor Therapeutics Forecasted Market Size by Type (2023-2028) 2.4 Chemotherapy 2.5 Hormone Therapy 2.6 Immunotherapy 2.7 Targeted Therapy 3 Solid Tumor Therapeutics Market Overview by Application 3.1 Global Solid Tumor Therapeutics Market Size by Application: 2017 VS 2021 VS 2028 3.2 Global Solid Tumor Therapeutics Historic Market Size by Application (2017-2022) 3.3 Global Solid Tumor Therapeutics Forecasted Market Size by Application (2023-2028) 3.4 Breast Cancer 3.5 Lung Cancer 3.6 Colorectal Cancer 3.7 Prostate Cancer 3.8 Cervical Cancer 3.9 Others 4 Solid Tumor Therapeutics Competition Analysis by Players 4.1 Global Solid Tumor Therapeutics Market Size by Players (2017-2022) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Tumor Therapeutics as of 2021) 4.3 Date of Key Players Enter into Solid Tumor Therapeutics Market 4.4 Global Top Players Solid Tumor Therapeutics Headquarters and Area Served 4.5 Key Players Solid Tumor Therapeutics Product Solution and Service 4.6 Competitive Status 4.6.1 Solid Tumor Therapeutics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Hoffmann-La Roche 5.1.1 Hoffmann-La Roche Profile 5.1.2 Hoffmann-La Roche Main Business 5.1.3 Hoffmann-La Roche Solid Tumor Therapeutics Products, Services and Solutions 5.1.4 Hoffmann-La Roche Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.1.5 Hoffmann-La Roche Recent Developments 5.2 Johnson & Johnson 5.2.1 Johnson & Johnson Profile 5.2.2 Johnson & Johnson Main Business 5.2.3 Johnson & Johnson Solid Tumor Therapeutics Products, Services and Solutions 5.2.4 Johnson & Johnson Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.2.5 Johnson & Johnson Recent Developments 5.3 Novartis 5.3.1 Novartis Profile 5.3.2 Novartis Main Business 5.3.3 Novartis Solid Tumor Therapeutics Products, Services and Solutions 5.3.4 Novartis Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.3.5 AstraZeneca Recent Developments 5.4 AstraZeneca 5.4.1 AstraZeneca Profile 5.4.2 AstraZeneca Main Business 5.4.3 AstraZeneca Solid Tumor Therapeutics Products, Services and Solutions 5.4.4 AstraZeneca Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.4.5 AstraZeneca Recent Developments 5.5 Biogen Idec 5.5.1 Biogen Idec Profile 5.5.2 Biogen Idec Main Business 5.5.3 Biogen Idec Solid Tumor Therapeutics Products, Services and Solutions 5.5.4 Biogen Idec Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.5.5 Biogen Idec Recent Developments 5.6 Boehringer Ingelheim 5.6.1 Boehringer Ingelheim Profile 5.6.2 Boehringer Ingelheim Main Business 5.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Products, Services and Solutions 5.6.4 Boehringer Ingelheim Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.6.5 Boehringer Ingelheim Recent Developments 5.7 GlaxoSmithKline 5.7.1 GlaxoSmithKline Profile 5.7.2 GlaxoSmithKline Main Business 5.7.3 GlaxoSmithKline Solid Tumor Therapeutics Products, Services and Solutions 5.7.4 GlaxoSmithKline Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.7.5 GlaxoSmithKline Recent Developments 5.8 Eli Lilly 5.8.1 Eli Lilly Profile 5.8.2 Eli Lilly Main Business 5.8.3 Eli Lilly Solid Tumor Therapeutics Products, Services and Solutions 5.8.4 Eli Lilly Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.8.5 Eli Lilly Recent Developments 5.9 Kyowa Hakko Kirin 5.9.1 Kyowa Hakko Kirin Profile 5.9.2 Kyowa Hakko Kirin Main Business 5.9.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Products, Services and Solutions 5.9.4 Kyowa Hakko Kirin Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.9.5 Kyowa Hakko Kirin Recent Developments 5.10 Abbott Laboratories 5.10.1 Abbott Laboratories Profile 5.10.2 Abbott Laboratories Main Business 5.10.3 Abbott Laboratories Solid Tumor Therapeutics Products, Services and Solutions 5.10.4 Abbott Laboratories Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.10.5 Abbott Laboratories Recent Developments 5.11 Baxter International 5.11.1 Baxter International Profile 5.11.2 Baxter International Main Business 5.11.3 Baxter International Solid Tumor Therapeutics Products, Services and Solutions 5.11.4 Baxter International Solid Tumor Therapeutics Revenue (US$ Million) & (2017-2022) 5.11.5 Baxter International Recent Developments 6 North America 6.1 North America Solid Tumor Therapeutics Market Size by Country (2017-2028) 6.2 U.S. 6.3 Canada 7 Europe 7.1 Europe Solid Tumor Therapeutics Market Size by Country (2017-2028) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 8 Asia-Pacific 8.1 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2017-2028) 8.2 China 8.3 Japan 8.4 South Korea 8.5 India 8.6 Australia 8.7 Taiwan 8.8 Indonesia 9 Latin America 9.1 Latin America Solid Tumor Therapeutics Market Size by Country (2017-2028) 9.2 Mexico 9.3 Brazil 9.4 Argentina 10 Middle East & Africa 10.1 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2017-2028) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 11 Solid Tumor Therapeutics Market Dynamics 11.1 Solid Tumor Therapeutics Industry Trends 11.2 Solid Tumor Therapeutics Market Drivers 11.3 Solid Tumor Therapeutics Market Challenges 11.4 Solid Tumor Therapeutics Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com